Pacira Biosciences, Inc.
Pacira BioSciences makes non-opioid pain treatments, best known for EXPAREL, a long-acting local anesthetic injected at the surgical site so patients recover from operations with less reliance on opioids. Its lineup also includes iovera°, a device that uses targeted cold to numb nerves. Founded in 2006 under the placeholder name Blue Acquisition Corp., the Tampa-based company later renamed itself Pacira and rebranded as Pacira BioSciences in 2019.
Sold 3.3K
Sold 10.3K
Granted 25.0K · Sold 25.0K
Sold 6.1K
Granted 6.4K
Granted 6.4K · Sold 500
Granted 6.4K
Granted 6.4K
Granted 6.4K
Granted 6.4K
Granted 6.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Slonin JonathanChief Medical Officer · 2 transactions | -3.5% | 218.9K | — | — | 3.3K |
| Williams KristenChief Administrative Officer · 2 transactions | -10.1% | 167.1K | — | — | 10.3K |
| Cross ShawnChief Financial Officer · 8 transactions | 0% | 105.3K | 25.0K | — | 25.0K |
| Riker LaurenSenior Vice President, Finance · 2 transactions | -13% | 62.3K | — | — | 6.1K |
| Brege LauraDirector · 1 transaction | +27% | 30.1K | 6.4K | — | — |
| Froimson MarkDirector · 2 transactions | +28.6% | 26.5K | 6.4K | — | 500 |
| Christie ChristopherDirector · 1 transaction | +38.5% | 23.1K | 6.4K | — | — |
| Yang Michael J.Director · 1 transaction | +47.8% | 19.8K | 6.4K | — | — |
| Bigal MarceloDirector · 1 transaction | +56.2% | 17.8K | 6.4K | — | — |
| Young AlethiaDirector · 1 transaction | +56.2% | 17.8K | 6.4K | — | — |
| Hirawat SamitDirector · 1 transaction | — | 6.4K | 6.4K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 6 months: -45.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.